Gayatri Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-12-2024
- Paid Up Capital ₹ 1.00 M
as on 09-12-2024
- Company Age 39 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.93 M
as on 09-12-2024
- Revenue -19.15%
(FY 2023)
- Profit 151.82%
(FY 2023)
- Ebitda -323.42%
(FY 2023)
- Net Worth 0.37%
(FY 2023)
- Total Assets -10.46%
(FY 2023)
About Gayatri Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹1.93 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Gauri Dash, Abhilash Dash, and Santoshini Dash serve as directors at the Company.
- CIN/LLPIN
U24231OR1985PTC001551
- Company No.
001551
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Aug 1985
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Cuttack, Odisha, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gayatri Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhilash Dash  | Managing Director | 31-Mar-2007 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gauri Dash | Director | 20-Jul-1988 | Current |
| Santoshini Dash | Director | 25-Oct-2005 | Current |
Financial Performance and Corporate Structure Insights of Gayatri Pharmaceuticals.
Gayatri Pharmaceuticals Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.15% decrease. The company also saw a substantial improvement in profitability, with a 151.82% increase in profit. The company's net worth moved up by a moderate rise of 0.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gayatri Pharmaceuticals?
Unlock access to Gayatri Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
The Odisha Small Industries Corporation LimitedActive 52 years 8 monthsGauri Dash is a mutual person
Rollex Kraft And Paper Private LimitedActive 1 year 3 monthsGauri Dash, Abhilash Dash and 1 more are mutual person
- Eastern Chemical Industrias Pvt LtdActive 38 years 5 months
Gauri Dash and Abhilash Dash are mutual person
- Rollex Paints And Chemicals Pvt LtdActive 44 years 8 days
Gauri Dash, Abhilash Dash and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Uco Bank Creation Date: 30 Nov 2009 | ₹1.00 M | Satisfied |
United Bank Of India Creation Date: 14 Oct 1988 | ₹0.93 M | Satisfied |
How Many Employees Work at Gayatri Pharmaceuticals?
Unlock and access historical data on people associated with Gayatri Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gayatri Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gayatri Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
